Publicacións en colaboración con investigadores/as de Hospital General Universitario de Valencia (119)

2025

  1. Retained products of conception (RPOC) and placental site nodule (PSN) in an isthmocele after a vaginal delivery: Diagnosis and laparoscopic repair

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 52, Núm. 1

2024

  1. Accuracy of ICG compared with technetium-99 m for sentinel lymph node biopsy in vulvar cancer

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 294, pp. 11-19

  2. Effect of aging on the human myometrium at single-cell resolution

    Nature Communications, Vol. 15, Núm. 1

  3. Endometrial cancer: predictors and oncological safety of tumor tissue manipulation

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1098-1105

  4. Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role

    European Journal of Surgical Oncology, Vol. 50, Núm. 4

  5. The Impact of Liquid Biopsy in Advanced Ovarian Cancer Care

    Diagnostics, Vol. 14, Núm. 17

  6. Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?

    Blood pressure

2023

  1. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

    Journal of hypertension, Vol. 41, Núm. 12, pp. 1874-2071

  2. Controversies in the treatment of endometriosis in sterile women

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 50, Núm. 3

  3. Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  4. Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients’ biofluids: Potential role in disease diagnosis and management

    Frontiers in Immunology, Vol. 14

  5. Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group

    Cancers, Vol. 15, Núm. 9

  6. Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  7. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study

    Cancers, Vol. 15, Núm. 17

  8. Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 6

  9. New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression

    International Journal of Molecular Sciences

  10. Prognostic factors in young women with epithelial ovarian cancer: the Young Ovarian Cancer-Care (YOC-Care) study

    International Journal of Gynecological Cancer

  11. Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets

    Cancers, Vol. 15, Núm. 12

  12. Simple radiologic assessment of visceral obesity and prediction of surgical morbidity in endometrial cancer patients undergoing laparoscopic aortic lymphadenectomy: A reliability and accuracy study

    Journal of Obstetrics and Gynaecology Research, Vol. 49, Núm. 3, pp. 988-997

  13. Special Issue “miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0”

    International Journal of Molecular Sciences